Medical Safety Alert: Crestor 5mg Tablets
In News
Follow this topic
Bookmark
Record learning outcomes
Potentially a rogue blister and carton may be present in a batch of Crestor 5mg Tablets €“ Class 4 Caution in Use (EL (16)A/03).
One pack of Crestor 5mg tablets parallel imported by BR Lewis Pharmaceuticals Ltd (originator name Provisacor) has been found to contain a rogue blister of 20mg tablets (batch S348A). The rogue blister was over-labelled as 5mg tablets, batch S347A/3153. The second blister in the pack was correct (5mg).
Pharmacists are asked to check any remaining stock of Crestor 5mg tablets batch S347A/3153 to ensure that the carton and both blisters are correct.
If a 20mg carton or blister is found, pharmacists should contact AAH Pharmaceuticals Regulatory Department, email: gb-AAHregulatory@AAH.co.uk; tel 02476 532359 to arrange uplift and credit.
For more details, see the MHRA's Medical Safety Alert.